EUVIMEDEUVIMED entdecken
Crossref

Comparative Review of Denosumab Versus Zoledronic Acid for the Reduction or Delay of Serious Complications Associated with Bone Metastases of Breast Cancer

Clinical Medicine Reviews in Oncology · 2010

DOI: 10.4137/cmro.s3249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Medicine Reviews in Oncology, 2010. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2010). Comparative Review of Denosumab Versus Zoledronic Acid for the Reduction or Delay of Serious Complications Associated with Bone Metastases of Breast Cancer. Clinical Medicine Reviews in Oncology. https://doi.org/10.4137/cmro.s3249

Vancouver

Comparative Review of Denosumab Versus Zoledronic Acid for the Reduction or Delay of Serious Complications Associated with Bone Metastases of Breast Cancer. Clinical Medicine Reviews in Oncology. 2010. doi:10.4137/cmro.s3249

BibTeX
@article{euvimed2010,
  title = {Comparative Review of Denosumab Versus Zoledronic Acid for the Reduction or Delay of Serious Complications Associated with Bone Metastases of Breast Cancer},
  journal = {Clinical Medicine Reviews in Oncology},
  year = {2010},
  doi = {10.4137/cmro.s3249}
}
Kostenlos starten →